2022年医学期刊发表中国皮肤病学指南和共识的科学性、透明性和适用性评级

Scientificity,transparency and applicability rankings of Chinese dermatological guidelines and consensus published in medical journals in 2022

目的评估并分析2022年期刊发表的中国皮肤病学指南和共识的科学性、透明性和适用性。方法在中国知网、万方数据知识服务平台、中国生物医学数据库、中华医学期刊网、Medline(PubMed)和Web of Science数据库中检索并筛选2022年中国皮肤病学领域发表的指南及共识。由指南和共识的科学性、透明性和适用性评级(STAR)皮肤科学专科委员会中获评级资格认证的委员采用STAR工具进行评级,每部指南或共识均由2位评价人员开展独立评价并交叉核对。计算指南及共识得分及各领域和各条目得分比例。结果共纳入中/英文指南及共识34部,包括指南11部,共识23部。STAR评级最高分84.6分,最低分4.3分,M(Q_(1),Q_(3))为20.7(12.7,29.3)分,平均得分24.7分。得分比例最高的3个领域分别为“推荐意见”领域(44.9%)、“其他”领域(44.1%)和“工作组”领域(31.8%),得分比例最低的3个领域分别为“计划书”领域(3.7%)、“资助”领域(9.8%)和“注册”领域(11.8%)。得分比例最高的条目为主要推荐意见有明确的参考文献(94.1%),得分比例最低的条目为计划书能够在公开平台获取(例如在注册平台或网站获取到)(0)。结论中国皮肤病学指南及共识的质量有待提升,建议重视规范化指南及共识的制订。

Objective To evaluate and analyze the scientificity,transparency and applicability of Chinese dermatological guidelines and consensus published in medical journals in 2022.Methods Guidelines and consensus developed by Chinese experts and published in the field of dermatology in 2022 were searched and screened in electronic databases including CNKI,Wanfang Data,SinoMed,Chinese Medical Journal Network,Medline(PubMed),Web of Science,etc.These guidelines and consensus were rated by qualified members of the Scientificity,Transparency and Applicability Rankings(STAR)-Dermatology Professional Committee using the STAR tool.Each guideline or consensus was independently evaluated and cross-checked by 2 evaluators.Guideline and consensus scores and the proportion of scores by fields and items were calculated.Results A total of 11 guidelines and 23 consensus statements published in Chinese or English were included.Their STAR scores ranged from 4.3 to 84.6 points,with a median score of 20.7 points(inter-quartile range Q_(1)-Q_(3),12.7-29.3)and a mean score of 24.7 points.The 3 fields with relatively high scores were"Recommendations"(44.9%),"Others"(44.1%)and"Working Group"(31.8%),and the 3 fields with relatively low scores were"Plans"(3.7%),“Funding”(9.8%)and“Registration”(11.8%).The item with the highest score was that clear references could be identified for the main recommendations(94.1%),and the item with the lowest score was that plans were accessible on open-source platforms(e.g.,plans could be obtained from registry platforms or websites)(0).Conclusion The quality of Chinese dermatological guidelines and consensus needs to be improved,and it is recommended to pay more attention to the development of standardized guidelines and consensus.